flecha

Producto

flecha
Exxiv®
Exxiv® is a product which relieves the symptoms of arthrosis, rheumatoid arthritis, and the pain and inflammatory symptoms associated with acute gouty arthritis. Its active ingredient is etoricoxib, a non-steroidal anti-inflammatory drug of the Cyclo
Exxiv® is a product which relieves the symptoms of arthrosis, rheumatoid arthritis, and the pain and inflammatory symptoms associated with acute gouty arthritis. Its active ingredient is etoricoxib, a non-steroidal anti-inflammatory drug of the Cyclooxygenase-2 inhibitor therapeutic group.

The effectiveness and safety of Exxiv® have been demonstrated in an extensive clinical programme (EDGE, EDGE II, MEDAL) which involved over 34,000 patients from across the world, and which demonstrated the benefits of treatment with etoricoxib compared to currently widely used anti-inflammatory drugs.

Exxiv® is available in different concentrations, depending on the pathology whose symptoms need treatment. It is available in film coated tablets of 60 mg (arthrosis), 90 mg (rheumatoid arthritis) and 120 mg of etoricoxib (acute gouty arthritis gotosa aguda, only during the acute symptomatic preiod (8 days)). It was developed by Merck Sharp & Dohme and has been marketed by ROVI since 2008.
 
 
Permalink  
Delicious  Technorati  Facebook  Twitter  Meneame 
Búsqueda
linea
Google Búsqueda personalizada
Área colaborativa de la BioRegión
Área colaborativa de la BioRegión
RSS
linea
RSS RSS Andalucía BioRegión
Acceso usuarios
linea
Email:
Contraseña:

Registrarse

¿Olvidó su contraseña?

Acceso empresas/centros
linea
Email:
Contraseña:

Registre su empresa

¿Olvidó su contraseña?

Nube de etiquetas
linea
Ver más etiquetas
Área colaborativa de la BioRegión